NMD670

· NMD Pharma A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NMD670, covering 2025-11-12 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy [Phase 2]